Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models
Science Advances · 05.12.2025 · 11 (49)
DOI: 10.1126/sciadv.adx2984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 05.12.2025. Verfasst von Md Mahfuzur Rahman und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Immunity, Innate, Immunotherapy, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is generally resistant to conventional immunotherapies due to its immunosuppressive tumor microenvironment (TME). We combine an innate cell–enriched product activated by interleukin-2 (IL-2) and zoledronic acid (ZA) (ICP IL2ZA ) with low-dose radiotherapy (RT) and monoclonal antibodies (mAbs) to overcome this immunosuppressive TME. ICP IL2ZA is composed of natural killer (NK) cell– and monocyte-enriched immune cells, activated ex vivo with IL-2 and ZA. ICP IL2ZA with RT and mAbs promotes antibody-dependent cellular cytotoxicity and phagocytosis against PDAC. In murine models of PDAC, RT and mAb combined with ICP IL2ZA derived from either murine or healthy human donors controlled tumor growth. RT amplifies ICP IL2ZA effectiveness by inducing NKG2D ligands on tumor cells, facilitating immune infiltration that leads to tumor growth control and extends survival without apparent toxicity. These results suggest that ICP IL2ZA can overcome limitations of traditional therapies by augmenting antitumor capabilities of endogenous immune cells, highlighting a promising autologous strategy for PDAC and other immunologically “cold” tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
- Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
- Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
- Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
- Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
ORCID-Profile: Md Mahfuzur Rahman, Andrea Pennati, Raad H Allawi, Ross O Meyers, Tracy J Berg, Zafer Gurel, Michael F Bassetti, Lu Mao, Paul M Sondel, Randall J Kimple, Christian M Capitini, Quaovi H Sodji, Jacques Galipeau, Zachary S Morris
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- Midwest Athletes Against Childhood Cancer
- St. Baldrick’s Foundation Empowering Pediatric Immunotherapy for Childhood Cancers
Zitieren
APA
Rahman, M. M., Pennati, A., Atajanova, T., Debnath, T., Allawi, R. H., Meyers, R. O., Berg, T. J., Gurel, Z., Uboha, N. V., Bassetti, M. F., Mao, L., Sondel, P. M., Kimple, R. J., Capitini, C. M., Sodji, Q. H., Galipeau, J., & Morris, Z. S. (2025). Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models. Science Advances, 11(49). https://doi.org/10.1126/sciadv.adx2984
Vancouver
Rahman MM, Pennati A, Atajanova T, Debnath T, Allawi RH, Meyers RO, et al. Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models. Science Advances. 2025;11(49). doi:10.1126/sciadv.adx2984
BibTeX
@article{Rahman2025,
author = {Rahman, Md Mahfuzur and Pennati, Andrea and Atajanova, Tavus and Debnath, Trishna and Allawi, Raad H and Meyers, Ross O and Berg, Tracy J and Gurel, Zafer and Uboha, Nataliya V and Bassetti, Michael F and Mao, Lu and Sondel, Paul M and Kimple, Randall J and Capitini, Christian M and Sodji, Quaovi H and Galipeau, Jacques and Morris, Zachary S},
title = {Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {49},
doi = {10.1126/sciadv.adx2984}
}
EUVIMED